Core Viewpoint - Jiuan Medical's stock price has experienced a slight decline, while the company anticipates significant profit growth in the upcoming half-year due to strong performance in asset management [1] Group 1: Stock Performance - As of August 6, 2025, Jiuan Medical's stock price is reported at 38.97 yuan, down 0.31% from the previous trading day [1] - The trading volume for the day reached 49,700 hands, with a total transaction amount of 193 million yuan [1] Group 2: Business Overview - Jiuan Medical's main business includes medical device manufacturing and new retail operations [1] - The new retail segment generated revenue of 6.295 million yuan in 2024, accounting for approximately 2.4% of total revenue, primarily from partnerships with Xiaomi and XPeng [1] Group 3: Financial Performance - The company has disclosed a profit forecast for the first half of 2025, expecting a net profit attributable to shareholders between 880 million and 980 million yuan, representing a year-on-year growth of 46.24% to 62.86% [1] - The growth in profits is mainly attributed to favorable performance in the asset management business [1] Group 4: Capital Flow - On August 6, 2025, the net outflow of main funds was 13.2233 million yuan, with a cumulative net outflow of 74.1832 million yuan over the past five days [1]